Tenax Therapeutics, Inc. (TENX)
Last updated: 2026-10-21 20:31:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Tenax Therapeutics, Inc. (TENX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.64, with a market capitalization of $56.88M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.31 to $19.40. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$56.88M | |
$1.65 | |
$152,320.00 | |
$1.31 | |
$1.63 | |
1.68M | |
5.71M | |
-- | |
$19.40 | |
$1.31 | |
-- | |
-- |
Tenax Therapeutics, Inc. (TENX) After-Hours Stock Price
Tenax Therapeutics, Inc. (TENX) is trading at $1.61 in after-hours trading as of 2026-10-21 20:24:00, down 1.47% ($0.02) from the regular-session close of $1.63.
After-hours trading shows how investors are pricing TENX after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Tenax Therapeutics, Inc. (TENX) 7-Day Stock Price Change
Over the past seven days, Tenax Therapeutics, Inc. (TENX) moved from $1.83 to $1.64, representing a decline of 10.66% ($0.20).
The stock traded between $1.36 and $1.88 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 2.62 million shares, up versus the previous seven-day period, indicating higher trading activity.
TENX 52-Week Price Position
Position in Range: 1.8%
TENX is currently trading at $1.64, placing it 1.8% of the way from its 52-week low of $1.31 to its 52-week high of $19.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Tenax Therapeutics, Inc. (TENX)?
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
Tenax Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 16 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Tenax Therapeutics, Inc. (TENX) Stock on MEXC
Eligible investors can buy real shares of Tenax Therapeutics, Inc. (TENX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Tenax Therapeutics, Inc. (TENX) stock price today?
2.Is TENX stock going up or down today?
3.What is TENX pre-market price?
4.What is TENX after-hours price?
5.Is TENX stock trading now?
6.Where does TENX sit relative to its 52-week high and low?
7.What sector is Tenax Therapeutics, Inc. in?
8.What is Tenax Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is TENX valued in terms of P/E ratio and EPS?
10.Does Tenax Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
TENX Stock Calculator
Estimate the value between TENX shares and USD.
TENX Shares to USD
1.00 TENX shares = 1.635 USD
Calculations are estimates based on the latest available price and are for reference only.


